Ligand Pharmaceuticals Inc. (LGND) Stock Price, Quote & AI Analysis

Live LGND stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Ligand Pharmaceuticals Inc..

TradeVae provides AI-driven analysis and real-time market intelligence for Ligand Pharmaceuticals Inc. (LGND), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

LGND
Ligand Pharmaceuticals Inc.
real-time
$0.00 +0.00 (+0.00%)
Open
213.200000
High
214.265000
Low
204.020000
Volume
468,323
VWAP
-
Market Cap
$3,901,310,538.40
52W Range
$93.58 - $227.92
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
May 6, 2026 Q1
Market
EPS Estimate: $1.9186
Revenue Estimate: $61,338,720.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Ligand Pharmaceuticals Inc.'s fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Ligand Pharmaceuticals Inc. Overview

Company information

Company Overview

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company that involves clinical development and commercialization of high-value medicines. Its platforms, Captisol and NITRICI, offer technology with broad applicability in drug development to a large network of biopharmaceutical partners, including the largest pharmaceutical manufacturers in the world. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.

Company Details
Market Cap
$4.09B
Shares Outstanding
19,941,142
Weighted Shares Outstanding
19,681,720
CEO
Todd Christopher Davis
Address
3911 SORRENTO VALLEY BLVD, SAN DIEGO, CA, 92121
Employees
68
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Ligand Pharmaceuticals Inc. Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...